Search Results - "Lintzeris, Nicholas"

Hydromorphone Hopes: A Qualitative Study of People Initiating Supervised Short‐Acting Injectable Opioid Treatment in Australia.

Authors: Rance, Jake Belackova, Vendula Bell, James et al.

Source: Drug & Alcohol Review. Jul2025, Vol. 44 Issue 5, p1533-1542.

Lisdexamfetamine in the treatment of methamphetamine dependence: A randomised, placebo‐controlled trial.

Authors: Ezard, Nadine Clifford, Brendan Siefried, Krista J. et al.

Source: Addiction. Jul2025, Vol. 120 Issue 7, p1345-1359.

Clinicians' Perspectives on Cannabis Use and Cannabis Treatment in Clients Undertaking Opioid Dependence Treatment.

Authors: Parvaresh, Laila Mills, Llewellyn Gholami, Jaleh et al.

Source: Drug & Alcohol Review. Jul2025, Vol. 44 Issue 5, p1339-1350.

Evaluation of an online postal take‐home naloxone service.

Authors: Harrod, Mary Ellen Sunjic, Sandra Pepolim, Lucy et al.

Source: Drug & Alcohol Review. Mar2025, Vol. 44 Issue 3, p696-703.

Treatment satisfaction and patient reported outcomes among people with opioid use disorder participating in an open‐label, non‐randomised trial of long‐acting injectable buprenorphine treatment in Australian custodial settings.

Authors: White, Bethany Little, Sophia Haber, Paul S. et al.

Source: Drug & Alcohol Review. Feb2025, Vol. 44 Issue 2, p640-648.

Integration of a facilitated access pathway for contraception into alcohol and other drug treatment services: A cohort study comparing metropolitan and regional settings.

Authors: McNamara, Kelly A. Murnion, Bridin Lintzeris, Nicholas et al.

Source: Drug & Alcohol Review. Jan2025, Vol. 44 Issue 1, p166-178.

Provider costs of treating opioid dependence with extended‐release buprenorphine in Australia.

Authors: Settumba, Stella Shahbazi, Jeyran Byrne, Marianne et al.

Source: Drug & Alcohol Review. Jan2025, Vol. 44 Issue 1, p179-194.

Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016–2019.

Authors: Black, Emma Mammen, Kristie Deacon, Rachel M. et al.

Source: Drug & Alcohol Review. Feb2023, Vol. 42 Issue 2, p389-400.

Identifying thresholds for clinically meaningful change among clients of drug and alcohol services using the Australian Treatment Outcomes Profile.

Authors: Deacon, Rachel M. Mills, Llewellyn Bruno, Raimondo et al.

Source: Addiction. Dec2023, Vol. 118 Issue 12, p2457-2465.

The DACRIN data project: A process for harmonising data collection for clinical research in alcohol and other drugs services in New South Wales.

Authors: Monds, Lauren A. Topp, Libby Pados, Jade et al.

Source: Drug & Alcohol Review. Sep2023, Vol. 42 Issue 6, p1422-1426.

The Overdose Response with Take Home Naloxone (ORTHN) project: Evaluation of health worker training, attitudes and perceptions.

Authors: Monds, Lauren A. Bravo, Maria Mills, Llewellyn et al.

Source: Drug & Alcohol Review. Jul2022, Vol. 41 Issue 5, p1085-1094.

Treatment of opioid dependence with depot buprenorphine (CAM2038) in custodial settings.

Authors: Dunlop, Adrian J. White, Bethany Roberts, Jillian et al.

Source: Addiction. Feb2022, Vol. 117 Issue 2, p382-391.

Understanding the research capacity of alcohol and other drugs services in New South Wales, Australia.

Authors: Stirling, Robert Hudson, Suzie Ross, Joanne et al.

Source: Drug & Alcohol Review. Jan2024, Vol. 43 Issue 1, p265-277.

Concerns and Experiences of Alcohol and Other Drug Healthcare Staff Regarding Intoxication Detection and Driving Safety of Opioid Treatment Clients.

Authors: Winter, Daniel T. Verón, Gabriel A. Day, Carolyn A. et al.

Source: Drug & Alcohol Review. Mar2026, Vol. 45 Issue 3, p1-7.

Risk Factors for Cognitive Impairment in Adults Attending Australian Community‐Based Substance Use Treatment Services.

Authors: Ridley, Nicole Wheeler, Ashley Francis, Heather M. et al.

Source: Drug & Alcohol Review. Feb2026, Vol. 45 Issue 2, p1-10.

Experiences of People Who Discontinue Long‐Acting Injectable Buprenorphine Treatment Recently Released From Prison in New South Wales, Australia.

Authors: Peck, Lucy J. D. White, Bethany Moensted, Maja et al.

Source: Drug & Alcohol Review. Feb2026, Vol. 45 Issue 2, p1-10.

What do general practitioners want from specialist alcohol and other drug services? A qualitative study of New South Wales metropolitan general practitioners.

Authors: Wilson, Hester Schulz, Michelle Rodgers, Craig et al.

Source: Drug & Alcohol Review. Jul2022, Vol. 41 Issue 5, p1152-1160.

Opioid agonist treatment and patient outcomes during the COVID‐19 pandemic in south east Sydney, Australia.

Authors: Lintzeris, Nicholas Deacon, Rachel M. Hayes, Victoria et al.

Source: Drug & Alcohol Review. Jul2022, Vol. 41 Issue 5, p1009-1019.

Determining clinical cutoff scores for the Australian Treatment Outcomes Profile psychological health, physical health and quality of life questions.

Authors: Mammen, Kristie Mills, Llewellyn Deacon, Rachel M. et al.

Source: Drug & Alcohol Review. Jan2022, Vol. 41 Issue 1, p106-113.

Factors Associated With Alcohol Use Among Individuals Commencing Treatment at Community‐Based Outpatient Treatment Centres in Australia.

Authors: Bryant, Jamie Shakeshaft, Anthony Lintzeris, Nicholas et al.

Source: Drug & Alcohol Review. Nov2025, Vol. 44 Issue 7, p2066-2079.